1. Villa-Cedillo, Sheila Adela, Acosta-Espinoza, Esrom Jared, Soto-Domínguez, Adolfo, Valdés, Jesús, Saucedo-Cárdenas, Odila. 2024. Antioxidant PRDX3 gene therapy protects brain cells and prevents neurodegeneration in an animal model of Parkinson's disease. In Neuropeptides, 110, 102494. doi:10.1016/j.npep.2024.102494. https://pubmed.ncbi.nlm.nih.gov/39736192/
2. Liu, Zhilei, Hu, Yadong, Liang, Haisha, Feng, Shan, Deng, Haiteng. 2016. Silencing PRDX3 Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells. In Journal of proteome research, 15, 1506-14. doi:10.1021/acs.jproteome.5b01125. https://pubmed.ncbi.nlm.nih.gov/26983019/
3. Wang, Guangyu, Wang, Bin, Qin, Qingtao, Zhao, Yuying, Lin, Pengfei. 2023. Exon Skipping Caused by Noncanonical Splicing Mutation in PRDX3-Related Spinocerebellar Ataxia. In Movement disorders : official journal of the Movement Disorder Society, 38, 1968-1970. doi:10.1002/mds.29575. https://pubmed.ncbi.nlm.nih.gov/37553955/
4. Rafeeq, Misbahuddin M, Umair, Muhammad, Bilal, Muhammad, Alam, Mohammad Zubair, Ali, Raja Hussain. 2022. A novel biallelic variant further delineates PRDX3-related autosomal recessive cerebellar ataxia. In Neurogenetics, 24, 55-60. doi:10.1007/s10048-022-00701-9. https://pubmed.ncbi.nlm.nih.gov/36190665/